Chester County News and Community Website
WASHINGTON, D.C. — Children with a rare genetic disorder that affects the brain and body will have access to a newly approved treatment designed to slow disease progression, federal regulators …
FDA Approves First Treatment Targeting Hunter Syndrome Brain Effects Read More
EXTON, PA — ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an oral NAD+ formulation designed to deliver …
ProRx’s Oral NAD+ Breakthrough Takes Aim at the Injection-Based Wellness Market Read More
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has unveiled its West Synchrony™ Prefillable Syringe (PFS) System, a new platform designed to simplify and accelerate the drug development process …
West Pharmaceutical Unveils Next-Generation Prefillable Syringe System for Biologics Read More
WAYNE, PA — Cagent Vascular has launched 7.0 mm and 8.0 mm sizes of its Serranator® PTA Serration Balloon Catheter, broadening the device’s use to larger vessels such as the …
Cagent Vascular Extends Serranator Line With Larger-Diameter Balloons for Complex PAD Cases Read More
MALVERN, PA — Endo, a subsidiary of Mallinckrodt plc, has expanded its ADRENALIN® line with the launch of three new FDA-approved premixed intravenous (IV) bag concentrations: 2 mg/250 mL, 5 …
Endo Expands ADRENALIN® Portfolio With New FDA-Approved Premixed IV Bags Read More
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has filed a complaint to stop Edwards Lifesciences Corp. from acquiring JenaValve Technology, Inc., citing fears the deal would significantly reduce competition …
FTC Moves to Block Edwards Lifesciences’ $945 Million Acquisition of JenaValve Over Competition Concerns Read More
EXTON, PA — Automated Financial Systems, Inc. (AFS®) has launched the AFS Pricing Dashboard, an advanced tool aimed at providing commercial banks with enhanced loan pricing intelligence for Commercial and …
AFS Unveils Innovative Pricing Dashboard for Commercial Banks Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of its QuikClot Control+™ Hemostatic …
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device Read More
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has filed a lawsuit seeking to block GTCR BC Holdings, LLC’s (GTCR) proposed acquisition of Surmodics, Inc., citing significant antitrust concerns. The …
FTC Fights to Block Merger Threatening Healthcare Innovation and Patient-Critical Devices Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced its recent approval of Ctexli (chenodiol), marking the first-ever treatment for cerebrotendinous xanthomatosis (CTX), a rare and debilitating …
FDA Breakthrough: First-Ever Treatment Approved for Rare and Devastating CTX Disorder! Read More